PASITHEA THERAPEUTICS CORP. Investing Cash Flow
PASITHEA THERAPEUTICS CORP. (KTTA) reported Investing Cash Flow of $11.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-30
- PASITHEA THERAPEUTICS CORP. net cash provided by (used in) investing activities for the quarter ending 2022-12-31 was -$1.76M.
- PASITHEA THERAPEUTICS CORP. net cash provided by (used in) investing activities for the quarter ending 2022-09-30 was -$230.43K.
- PASITHEA THERAPEUTICS CORP. net cash provided by (used in) investing activities for the quarter ending 2022-06-30 was $38.75K.
- PASITHEA THERAPEUTICS CORP. net cash provided by (used in) investing activities for the quarter ending 2022-03-31 was -$113.87K.
- PASITHEA THERAPEUTICS CORP. net cash provided by (used in) investing activities for fiscal 2025 was $11.00K.
- PASITHEA THERAPEUTICS CORP. net cash provided by (used in) investing activities for fiscal 2022 was -$2.06M.
- PASITHEA THERAPEUTICS CORP. net cash provided by (used in) investing activities for fiscal 2021 was -$21.50K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $11.00K 10-K · filed 2026-03-30 | |||
| 2022-12-31 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.99M derived: sum of 2 quarters · filed 2023-03-30 | -$1.95M derived: sum of 3 quarters · filed 2023-03-30 | -$2.06M 10-K · filed 2023-03-30 |
| 2022-09-30 | -$230.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$191.68K derived: sum of 2 quarters · filed 2022-11-14 | -$305.55K 10-Q · filed 2022-11-14 | -$318.48K derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-06-30 | $38.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$75.12K 10-Q · filed 2022-08-15 | -$88.05K derived: sum of 3 quarters · filed 2023-03-30 | |
| 2022-03-31 | -$113.87K 10-Q · filed 2022-05-16 | -$126.80K derived: sum of 2 quarters · filed 2023-03-30 | ||
| 2021-12-31 | -$12.93K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$21.50K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | -$8.57K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |